CD38 - Wikipedia
Immunophenotyping in Multiple Myeloma and Others Monoclonal Gammopathies | IntechOpen
Cureus | CD38: From Positive to Negative Expression after Daratumumab Treatment | Article
In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma | Journal of Hematology & Oncology | Full Text
JCM | Free Full-Text | Resistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma
Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide
Detect CD38 expression during anti-CD38 therapy – Caltag Medsystems
CD38 expression and function in NK cells. (A) Role of CD38 in the... | Download Scientific Diagram
Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From Tumor–Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy
![PDF] Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/72ce80f2da87d037624955a597846d530a0c6052/3-Figure1-1.png "PDF] Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma | Semantic Scholar")
PDF] Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma | Semantic Scholar
Cells | Free Full-Text | CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents
Pre-treatment CD38-positive regulatory T cells affect the durable response to daratumumab in relapsed/refractory multiple myeloma patients | Haematologica
Expression of CD38 in normal and malignant plasma cells.... | Download Scientific Diagram
Cureus | Secondary Plasma Cell Leukemia in a Recurrent Multiple Myeloma: Rare Case Scenario | Article
Regulation of CD38 on Multiple Myeloma and NK Cells by Monoclonal Antibodies
Frontiers | CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
![Annotating CD38 Expression in Multiple Myeloma with [18F]F–Nb1053 | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.1c00733/asset/images/acs.molpharmaceut.1c00733.social.jpeg_v03 "Annotating CD38 Expression in Multiple Myeloma with [18F]F–Nb1053 | Molecular Pharmaceutics")
Annotating CD38 Expression in Multiple Myeloma with [18F]F–Nb1053 | Molecular Pharmaceutics
Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab | Leukemia
International Clinical Cytometry Society
